P179. Comparing roll and magseed in management of impalpable breast lesions a single unit experience
Published Date: 01st May 2021
Publication Authors: Jois RHS, Pushdary KH, Patnam V, Gupta N, Kiernan T, Bathla S, Ray A, Harris O, Chagla LS
Background
Screening and the use of Neoadjuvant therapy has increased the number of breast lesions requiring localisation. The search for the ideal technique is still on. ROLL (Radioisotope guided Occult Lesion Localisation) is a reliable technique though not widely available, Magnetic Seed, is a new alternative. These two techniques have never been compared.
Aim(s)
Compare the outcomes of ROLL and MAGSEED in managing occult breast lesion.
Material(s) and Method(s)
Prospectively data collected for both techniques, for patients undergoing localisation during Dec 2018 - Oct 2019. Data analysis was carried out with SPSS 22 software for the parameters described below.
Result(s)
* Total patients 101. * Roll 50 pts, Magseed 50 pts, (one was excluded as she had both) * Median age; 62 (34-83 years). * Median BMI 28.1 (18-52). * Ultrasound localisation 73 (73%). * Invasive ductal cancer 80 (80%). * Re-excision rate 9 (9%). No statistically significant difference was observed between the two groups for - BMI, age, type of surgery, operative time, margin status, re-excision rates, specimen volume, specimen weight, tumor size or hospital stay. However, significant difference (p<0.001) observed for time to surgery from localisation and cost per procedure.
Conclusion(s)
Surgical outcomes for two techniques are similar. ROLL surgery must be performed within 24 hours of localisation. Magseed offers the benefit of planning localisation in advance, hence, theatre scheduling and ability to visualise the seed radiologically has made this technique popular. The cost per Magseed is much expensive in comparison to isotope in ROLL.
Jois, R; Pushdary, K; Patnam, V; Gupta, N; Kiernan, T; Bathla, S; Ray, A; Harris, O; Chagla, L. (2021). P179. Comparing roll and magseed in management of impalpable breast lesions a single unit experience. European Journal of Surgical Oncology. 47 (5), E344